Jetbest (4741) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.026x

Based on the latest financial reports, Jetbest (4741) has a cash flow conversion efficiency ratio of 0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$24.06 Million ≈ $757.96K USD) by net assets (NT$917.60 Million ≈ $28.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 4741 market cap for the company's overall valuation and market capitalisation.

Jetbest - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Jetbest's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jetbest Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jetbest ranked by their cash flow conversion efficiency. Explore Jetbest (4741) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
JP Morgan Global Growth & Income PLC
LSE:JGGI
0.004x
Petershill Partners PLC
LSE:PHLL
0.014x
Triller Group Inc. Common Stock
NYSE:ILLR
0.013x
Circle8 Group, Inc.
NASDAQ:CIRC
-0.181x
G.I. Tech Co. Ltd.
KQ:382480
0.020x
Suparma Tbk
JK:SPMA
0.049x
Gemvaxlink Co. Ltd
KQ:064800
0.009x
Planet Image International Limited Class A Ordinary Shares
NASDAQ:YIBO
-0.077x

Annual Cash Flow Conversion Efficiency for Jetbest (2009–2025)

The table below shows the annual cash flow conversion efficiency of Jetbest from 2009 to 2025. View Jetbest (4741) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$917.60 Million
≈ $28.91 Million
NT$34.26 Million
≈ $1.08 Million
0.037x -67.78%
2024-12-31 NT$949.39 Million
≈ $29.91 Million
NT$110.01 Million
≈ $3.47 Million
0.116x -30.20%
2023-12-31 NT$943.74 Million
≈ $29.73 Million
NT$156.67 Million
≈ $4.94 Million
0.166x +49.76%
2022-12-31 NT$933.35 Million
≈ $29.41 Million
NT$103.46 Million
≈ $3.26 Million
0.111x +76.35%
2021-12-31 NT$908.80 Million
≈ $28.63 Million
NT$57.12 Million
≈ $1.80 Million
0.063x -37.77%
2020-12-31 NT$900.93 Million
≈ $28.38 Million
NT$91.00 Million
≈ $2.87 Million
0.101x +59.18%
2019-12-31 NT$910.42 Million
≈ $28.68 Million
NT$57.77 Million
≈ $1.82 Million
0.063x -36.81%
2018-12-31 NT$934.26 Million
≈ $29.43 Million
NT$93.82 Million
≈ $2.96 Million
0.100x -30.42%
2017-12-31 NT$953.02 Million
≈ $30.03 Million
NT$137.54 Million
≈ $4.33 Million
0.144x -24.90%
2016-12-31 NT$735.60 Million
≈ $23.18 Million
NT$141.37 Million
≈ $4.45 Million
0.192x -7.89%
2015-12-31 NT$738.93 Million
≈ $23.28 Million
NT$154.18 Million
≈ $4.86 Million
0.209x -17.09%
2014-12-31 NT$701.19 Million
≈ $22.09 Million
NT$176.46 Million
≈ $5.56 Million
0.252x -36.18%
2013-12-31 NT$504.18 Million
≈ $15.88 Million
NT$198.82 Million
≈ $6.26 Million
0.394x +20.20%
2012-12-31 NT$420.03 Million
≈ $13.23 Million
NT$137.80 Million
≈ $4.34 Million
0.328x +55.96%
2011-12-31 NT$341.30 Million
≈ $10.75 Million
NT$71.79 Million
≈ $2.26 Million
0.210x +3.41%
2010-12-31 NT$337.71 Million
≈ $10.64 Million
NT$68.69 Million
≈ $2.16 Million
0.203x +31.97%
2009-12-31 NT$285.61 Million
≈ $9.00 Million
NT$44.02 Million
≈ $1.39 Million
0.154x --

About Jetbest

TWO:4741 Taiwan Specialty Chemicals
Market Cap
$40.85 Million
NT$1.30 Billion TWD
Market Cap Rank
#22745 Global
#1400 in Taiwan
Share Price
NT$37.25
Change (1 day)
+1.22%
52-Week Range
NT$20.50 - NT$81.00
All Time High
NT$81.00
About

Jetbest Corporation engages in the research, development, manufacture, and sale of inkjet printing products in Taiwan. The company provides wide format inks, such as UV inks, eco solvent pigment inks, and water dye and pigment inks; textile inks, including dye sublimation inks, direct to film printing, and direct glue to film printing; and latex, magic, and desktop inks. It also offers pigment mi… Read more